Recursion Pharmaceuticals (RXRX) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.45
-0.43
-0.4
-0.38

Details

Expected EPS
-0.384286
Actual EPS
-0.4
Surprise EPS
-0.02
Surprise Percent
+4.09%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.4 per share for Q3 2024.

0 Comments

Share your thoughts